Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
- Róbert Wessman to continue serving as Executive Chairman in full-time capacity - Lisa Graver appointed Chief Executive Officer REYKJAVIK, Iceland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech...
-
Amsterdam – HERE Technologies, the leading digital mapping and location data company, has once again been named the #1 location platform by Omdia, a global technology research leader. The 2025 Omdia...
-
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced that the...
-
REYKJAVÍK - (16. DESEMBER 2025) Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að fyrirtækið efni til útboðs á breytanlegum skuldabréfum að fjárhæð 100 milljónir dollara með gjalddaga á árinu 2030....
-
Dublin, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The "Black Rice Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The black rice market is rapidly...
-
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (the “Company”) (Nasdaq: LOT) today provided an update on its new plug-in hybrid (PHEV) model. The model made its public debut on...
-
SAN DIEGO and TAIPEI, Taiwan, Dec. 01, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Lotus Pharmaceutical Co., Ltd. (“Lotus”, TWSW Stock Code: 1795) today announced that Lotus...
-
VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Leviathan Metals Corp. (“Leviathan” or the “Company”) (LVX – TSXV, LVXFF – OTC, 0GP – FSE) is pleased to announce closing of its...
-
REYKJAVÍK, 25. NÓVEMBER 2025 - Alvotech (NASDAQ: ALVO) tilkynnti í dag að Framkvæmdastjórn Evrópusambandsins hafi veitt markaðsleyfi á Evrópska efnahagssvæðinu fyrir AVT03, hliðstæðu við...
-
REYKJAVIK, ICELAND (November 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today...